Latest Updates

Further talks with GSK will depend on the results of its due-diligence process

Others include sustainability, Brexit, the US election and digital health

Engagement in systematic access planning has increased from one company in 2018 to 40 per cent of companies in the Index this year

We are fulfilling our commitment to make our vaccine production and delivery capacity available for the benefit of the entire…

Allows state licensing authority of ASU to take necessary action

The company said it found no reduction in the antibody response against the variant found in Britain

Dr Tuck Seng Wong, Director of International Student Recruitment and Senior Lecturer, Department of Chemical and Biological…

Data released in November from Moderna’s late-stage study showed it was 94.1 per cent effective with no serious safety concerns

Sushil Khaitan, CEO & Director at Purenutrition.in opines that given the size of the nutraceutical industry in India today, it…

This is the fourth year in a row Takeda has received the global Top Employer status